Skip to content

Drug interactions

Eplerenone + Zafirlukast

Severity: Minor

Eplerenone and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eplerenone is a sensitive CYP3A4 substrate, and zafirlukast may modestly raise its exposure. The main concern would be hyperkalemia, though the effect of a weak inhibitor is expected to be small.

What this interaction means in plain words

Eplerenone and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eplerenone belongs to Cardiovascular; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by zafirlukast may reduce eplerenone clearance.

What to do

Monitor serum potassium and renal function as routinely recommended with eplerenone.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eplerenone and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eplerenone with Zafirlukast?

MediHelp rates the interaction as minor. Eplerenone and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eplerenone is a sensitive CYP3A4 substrate, and zafirlukast may modestly raise its exposure. The main concern would be hyperkalemia, though the effect of a weak inhibitor is expected to be small.

How serious is the interaction between Eplerenone and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function as routinely recommended with eplerenone.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in